Global Opioids Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Opioids Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Opioids by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Opioids by Country/Region, 2017, 2022 & 2028

2.2 Opioids Segment by Type

2.2.1 Oxycodone

2.2.2 Hydromorphone

2.2.3 Codeine

2.2.4 Fentanyl

2.2.5 Other

2.3 Opioids Sales by Type

2.3.1 Global Opioids Sales Market Share by Type (2017-2022)

2.3.2 Global Opioids Revenue and Market Share by Type (2017-2022)

2.3.3 Global Opioids Sale Price by Type (2017-2022)

2.4 Opioids Segment by Application

2.4.1 Pain Relief

2.4.2 Anesthesia

2.4.3 Cough Suppression

2.4.4 Diarrhea Suppression

2.4.5 Deaddiction

2.4.6 Others

2.5 Opioids Sales by Application

2.5.1 Global Opioids Sale Market Share by Application (2017-2022)

2.5.2 Global Opioids Revenue and Market Share by Application (2017-2022)

2.5.3 Global Opioids Sale Price by Application (2017-2022)

3 Global Opioids by Company

3.1 Global Opioids Breakdown Data by Company

3.1.1 Global Opioids Annual Sales by Company (2020-2022)

3.1.2 Global Opioids Sales Market Share by Company (2020-2022)

3.2 Global Opioids Annual Revenue by Company (2020-2022)

3.2.1 Global Opioids Revenue by Company (2020-2022)

3.2.2 Global Opioids Revenue Market Share by Company (2020-2022)

3.3 Global Opioids Sale Price by Company

3.4 Key Manufacturers Opioids Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Opioids Product Location Distribution

3.4.2 Players Opioids Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Opioids by Geographic Region

4.1 World Historic Opioids Market Size by Geographic Region (2017-2022)

4.1.1 Global Opioids Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Opioids Annual Revenue by Geographic Region

4.2 World Historic Opioids Market Size by Country/Region (2017-2022)

4.2.1 Global Opioids Annual Sales by Country/Region (2017-2022)

4.2.2 Global Opioids Annual Revenue by Country/Region

4.3 Americas Opioids Sales Growth

4.4 APAC Opioids Sales Growth

4.5 Europe Opioids Sales Growth

4.6 Middle East & Africa Opioids Sales Growth

5 Americas

5.1 Americas Opioids Sales by Country

5.1.1 Americas Opioids Sales by Country (2017-2022)

5.1.2 Americas Opioids Revenue by Country (2017-2022)

5.2 Americas Opioids Sales by Type

5.3 Americas Opioids Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Opioids Sales by Region

6.1.1 APAC Opioids Sales by Region (2017-2022)

6.1.2 APAC Opioids Revenue by Region (2017-2022)

6.2 APAC Opioids Sales by Type

6.3 APAC Opioids Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Opioids by Country

7.1.1 Europe Opioids Sales by Country (2017-2022)

7.1.2 Europe Opioids Revenue by Country (2017-2022)

7.2 Europe Opioids Sales by Type

7.3 Europe Opioids Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Opioids by Country

8.1.1 Middle East & Africa Opioids Sales by Country (2017-2022)

8.1.2 Middle East & Africa Opioids Revenue by Country (2017-2022)

8.2 Middle East & Africa Opioids Sales by Type

8.3 Middle East & Africa Opioids Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Opioids

10.3 Manufacturing Process Analysis of Opioids

10.4 Industry Chain Structure of Opioids

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Opioids Distributors

11.3 Opioids Customer

12 World Forecast Review for Opioids by Geographic Region

12.1 Global Opioids Market Size Forecast by Region

12.1.1 Global Opioids Forecast by Region (2023-2028)

12.1.2 Global Opioids Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Opioids Forecast by Type

12.7 Global Opioids Forecast by Application

13 Key Players Analysis

13.1 Teva

13.1.1 Teva Company Information

13.1.2 Teva Opioids Product Offered

13.1.3 Teva Opioids Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Teva Main Business Overview

13.1.5 Teva Latest Developments

13.2 Purdue Pharma

13.2.1 Purdue Pharma Company Information

13.2.2 Purdue Pharma Opioids Product Offered

13.2.3 Purdue Pharma Opioids Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Purdue Pharma Main Business Overview

13.2.5 Purdue Pharma Latest Developments

13.3 Mallinckrodt

13.3.1 Mallinckrodt Company Information

13.3.2 Mallinckrodt Opioids Product Offered

13.3.3 Mallinckrodt Opioids Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Mallinckrodt Main Business Overview

13.3.5 Mallinckrodt Latest Developments

13.4 Amneal Pharma

13.4.1 Amneal Pharma Company Information

13.4.2 Amneal Pharma Opioids Product Offered

13.4.3 Amneal Pharma Opioids Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Amneal Pharma Main Business Overview

13.4.5 Amneal Pharma Latest Developments

13.5 Collegium

13.5.1 Collegium Company Information

13.5.2 Collegium Opioids Product Offered

13.5.3 Collegium Opioids Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Collegium Main Business Overview

13.5.5 Collegium Latest Developments

13.6 J&J

13.6.1 J&J Company Information

13.6.2 J&J Opioids Product Offered

13.6.3 J&J Opioids Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 J&J Main Business Overview

13.6.5 J&J Latest Developments

13.7 Endo

13.7.1 Endo Company Information

13.7.2 Endo Opioids Product Offered

13.7.3 Endo Opioids Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Endo Main Business Overview

13.7.5 Endo Latest Developments

13.8 Pfizer

13.8.1 Pfizer Company Information

13.8.2 Pfizer Opioids Product Offered

13.8.3 Pfizer Opioids Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Pfizer Main Business Overview

13.8.5 Pfizer Latest Developments

13.9 INSYS

13.9.1 INSYS Company Information

13.9.2 INSYS Opioids Product Offered

13.9.3 INSYS Opioids Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 INSYS Main Business Overview

13.9.5 INSYS Latest Developments

13.10 Mylan

13.10.1 Mylan Company Information

13.10.2 Mylan Opioids Product Offered

13.10.3 Mylan Opioids Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Mylan Main Business Overview

13.10.5 Mylan Latest Developments

13.11 Hikma

13.11.1 Hikma Company Information

13.11.2 Hikma Opioids Product Offered

13.11.3 Hikma Opioids Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Hikma Main Business Overview

13.11.5 Hikma Latest Developments

13.12 Egalet

13.12.1 Egalet Company Information

13.12.2 Egalet Opioids Product Offered

13.12.3 Egalet Opioids Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Egalet Main Business Overview

13.12.5 Egalet Latest Developments

14 Research Findings and Conclusion

Table 1. Opioids Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Opioids Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oxycodone

Table 4. Major Players of Hydromorphone

Table 5. Major Players of Codeine

Table 6. Major Players of Fentanyl

Table 7. Major Players of Other

Table 8. Global Opioids Sales by Type (2017-2022) & (MT)

Table 9. Global Opioids Sales Market Share by Type (2017-2022)

Table 10. Global Opioids Revenue by Type (2017-2022) & ($ million)

Table 11. Global Opioids Revenue Market Share by Type (2017-2022)

Table 12. Global Opioids Sale Price by Type (2017-2022) & (USD/Kg)

Table 13. Global Opioids Sales by Application (2017-2022) & (MT)

Table 14. Global Opioids Sales Market Share by Application (2017-2022)

Table 15. Global Opioids Revenue by Application (2017-2022)

Table 16. Global Opioids Revenue Market Share by Application (2017-2022)

Table 17. Global Opioids Sale Price by Application (2017-2022) & (USD/Kg)

Table 18. Global Opioids Sales by Company (2020-2022) & (MT)

Table 19. Global Opioids Sales Market Share by Company (2020-2022)

Table 20. Global Opioids Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Opioids Revenue Market Share by Company (2020-2022)

Table 22. Global Opioids Sale Price by Company (2020-2022) & (USD/Kg)

Table 23. Key Manufacturers Opioids Producing Area Distribution and Sales Area

Table 24. Players Opioids Products Offered

Table 25. Opioids Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Opioids Sales by Geographic Region (2017-2022) & (MT)

Table 29. Global Opioids Sales Market Share Geographic Region (2017-2022)

Table 30. Global Opioids Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Opioids Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Opioids Sales by Country/Region (2017-2022) & (MT)

Table 33. Global Opioids Sales Market Share by Country/Region (2017-2022)

Table 34. Global Opioids Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Opioids Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Opioids Sales by Country (2017-2022) & (MT)

Table 37. Americas Opioids Sales Market Share by Country (2017-2022)

Table 38. Americas Opioids Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Opioids Revenue Market Share by Country (2017-2022)

Table 40. Americas Opioids Sales by Type (2017-2022) & (MT)

Table 41. Americas Opioids Sales Market Share by Type (2017-2022)

Table 42. Americas Opioids Sales by Application (2017-2022) & (MT)

Table 43. Americas Opioids Sales Market Share by Application (2017-2022)

Table 44. APAC Opioids Sales by Region (2017-2022) & (MT)

Table 45. APAC Opioids Sales Market Share by Region (2017-2022)

Table 46. APAC Opioids Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Opioids Revenue Market Share by Region (2017-2022)

Table 48. APAC Opioids Sales by Type (2017-2022) & (MT)

Table 49. APAC Opioids Sales Market Share by Type (2017-2022)

Table 50. APAC Opioids Sales by Application (2017-2022) & (MT)

Table 51. APAC Opioids Sales Market Share by Application (2017-2022)

Table 52. Europe Opioids Sales by Country (2017-2022) & (MT)

Table 53. Europe Opioids Sales Market Share by Country (2017-2022)

Table 54. Europe Opioids Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Opioids Revenue Market Share by Country (2017-2022)

Table 56. Europe Opioids Sales by Type (2017-2022) & (MT)

Table 57. Europe Opioids Sales Market Share by Type (2017-2022)

Table 58. Europe Opioids Sales by Application (2017-2022) & (MT)

Table 59. Europe Opioids Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Opioids Sales by Country (2017-2022) & (MT)

Table 61. Middle East & Africa Opioids Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Opioids Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Opioids Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Opioids Sales by Type (2017-2022) & (MT)

Table 65. Middle East & Africa Opioids Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Opioids Sales by Application (2017-2022) & (MT)

Table 67. Middle East & Africa Opioids Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Opioids

Table 69. Key Market Challenges & Risks of Opioids

Table 70. Key Industry Trends of Opioids

Table 71. Opioids Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Opioids Distributors List

Table 74. Opioids Customer List

Table 75. Global Opioids Sales Forecast by Region (2023-2028) & (MT)

Table 76. Global Opioids Sales Market Forecast by Region

Table 77. Global Opioids Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Opioids Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Opioids Sales Forecast by Country (2023-2028) & (MT)

Table 80. Americas Opioids Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Opioids Sales Forecast by Region (2023-2028) & (MT)

Table 82. APAC Opioids Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Opioids Sales Forecast by Country (2023-2028) & (MT)

Table 84. Europe Opioids Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Opioids Sales Forecast by Country (2023-2028) & (MT)

Table 86. Middle East & Africa Opioids Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Opioids Sales Forecast by Type (2023-2028) & (MT)

Table 88. Global Opioids Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Opioids Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Opioids Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Opioids Sales Forecast by Application (2023-2028) & (MT)

Table 92. Global Opioids Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Opioids Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Opioids Revenue Market Share Forecast by Application (2023-2028)

Table 95. Teva Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors

Table 96. Teva Opioids Product Offered

Table 97. Teva Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 98. Teva Main Business

Table 99. Teva Latest Developments

Table 100. Purdue Pharma Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors

Table 101. Purdue Pharma Opioids Product Offered

Table 102. Purdue Pharma Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 103. Purdue Pharma Main Business

Table 104. Purdue Pharma Latest Developments

Table 105. Mallinckrodt Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors

Table 106. Mallinckrodt Opioids Product Offered

Table 107. Mallinckrodt Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 108. Mallinckrodt Main Business

Table 109. Mallinckrodt Latest Developments

Table 110. Amneal Pharma Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors

Table 111. Amneal Pharma Opioids Product Offered

Table 112. Amneal Pharma Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 113. Amneal Pharma Main Business

Table 114. Amneal Pharma Latest Developments

Table 115. Collegium Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors

Table 116. Collegium Opioids Product Offered

Table 117. Collegium Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 118. Collegium Main Business

Table 119. Collegium Latest Developments

Table 120. J&J Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors

Table 121. J&J Opioids Product Offered

Table 122. J&J Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 123. J&J Main Business

Table 124. J&J Latest Developments

Table 125. Endo Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors

Table 126. Endo Opioids Product Offered

Table 127. Endo Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 128. Endo Main Business

Table 129. Endo Latest Developments

Table 130. Pfizer Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors

Table 131. Pfizer Opioids Product Offered

Table 132. Pfizer Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 133. Pfizer Main Business

Table 134. Pfizer Latest Developments

Table 135. INSYS Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors

Table 136. INSYS Opioids Product Offered

Table 137. INSYS Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 138. INSYS Main Business

Table 139. INSYS Latest Developments

Table 140. Mylan Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors

Table 141. Mylan Opioids Product Offered

Table 142. Mylan Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 143. Mylan Main Business

Table 144. Mylan Latest Developments

Table 145. Hikma Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors

Table 146. Hikma Opioids Product Offered

Table 147. Hikma Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 148. Hikma Main Business

Table 149. Hikma Latest Developments

Table 150. Egalet Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors

Table 151. Egalet Opioids Product Offered

Table 152. Egalet Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 153. Egalet Main Business

Table 154. Egalet Latest Developments

List of Figures

Figure 1. Picture of Opioids

Figure 2. Opioids Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Opioids Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Opioids Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Opioids Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oxycodone

Figure 10. Product Picture of Hydromorphone

Figure 11. Product Picture of Codeine

Figure 12. Product Picture of Fentanyl

Figure 13. Product Picture of Other

Figure 14. Global Opioids Sales Market Share by Type in 2021

Figure 15. Global Opioids Revenue Market Share by Type (2017-2022)

Figure 16. Opioids Consumed in Pain Relief

Figure 17. Global Opioids Market: Pain Relief (2017-2022) & (MT)

Figure 18. Opioids Consumed in Anesthesia

Figure 19. Global Opioids Market: Anesthesia (2017-2022) & (MT)

Figure 20. Opioids Consumed in Cough Suppression

Figure 21. Global Opioids Market: Cough Suppression (2017-2022) & (MT)

Figure 22. Opioids Consumed in Diarrhea Suppression

Figure 23. Global Opioids Market: Diarrhea Suppression (2017-2022) & (MT)

Figure 24. Opioids Consumed in Deaddiction

Figure 25. Global Opioids Market: Deaddiction (2017-2022) & (MT)

Figure 26. Opioids Consumed in Others

Figure 27. Global Opioids Market: Others (2017-2022) & (MT)

Figure 28. Global Opioids Sales Market Share by Application (2017-2022)

Figure 29. Global Opioids Revenue Market Share by Application in 2021

Figure 30. Opioids Revenue Market by Company in 2021 ($ Million)

Figure 31. Global Opioids Revenue Market Share by Company in 2021

Figure 32. Global Opioids Sales Market Share by Geographic Region (2017-2022)

Figure 33. Global Opioids Revenue Market Share by Geographic Region in 2021

Figure 34. Global Opioids Sales Market Share by Region (2017-2022)

Figure 35. Global Opioids Revenue Market Share by Country/Region in 2021

Figure 36. Americas Opioids Sales 2017-2022 (MT)

Figure 37. Americas Opioids Revenue 2017-2022 ($ Millions)

Figure 38. APAC Opioids Sales 2017-2022 (MT)

Figure 39. APAC Opioids Revenue 2017-2022 ($ Millions)

Figure 40. Europe Opioids Sales 2017-2022 (MT)

Figure 41. Europe Opioids Revenue 2017-2022 ($ Millions)

Figure 42. Middle East & Africa Opioids Sales 2017-2022 (MT)

Figure 43. Middle East & Africa Opioids Revenue 2017-2022 ($ Millions)

Figure 44. Americas Opioids Sales Market Share by Country in 2021

Figure 45. Americas Opioids Revenue Market Share by Country in 2021

Figure 46. United States Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 47. Canada Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 48. Mexico Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 49. Brazil Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 50. APAC Opioids Sales Market Share by Region in 2021

Figure 51. APAC Opioids Revenue Market Share by Regions in 2021

Figure 52. China Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 53. Japan Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 54. South Korea Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 55. Southeast Asia Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 56. India Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 57. Australia Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 58. Europe Opioids Sales Market Share by Country in 2021

Figure 59. Europe Opioids Revenue Market Share by Country in 2021

Figure 60. Germany Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 61. France Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 62. UK Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 63. Italy Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 64. Russia Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 65. Middle East & Africa Opioids Sales Market Share by Country in 2021

Figure 66. Middle East & Africa Opioids Revenue Market Share by Country in 2021

Figure 67. Egypt Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 68. South Africa Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 69. Israel Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 70. Turkey Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 71. GCC Country Opioids Revenue Growth 2017-2022 ($ Millions)

Figure 72. Manufacturing Cost Structure Analysis of Opioids in 2021

Figure 73. Manufacturing Process Analysis of Opioids

Figure 74. Industry Chain Structure of Opioids

Figure 75. Channels of Distribution

Figure 76. Distributors Profiles